Literature DB >> 9032391

Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate.

J C Zong1, C Metroka, M S Reitz, J Nicholas, G S Hayward.   

Abstract

Previous analysis of the majority of Kaposi's sarcoma (KS) tumors, in both AIDS and non-AIDS populations, has revealed the consistent presence of two small subsegments (open reading frame 25/26 [ORF25/26] and ORF75) of a novel human gamma class herpesvirus genome referred to as KSHV or HHV-8. We have carried out DNA sequence comparisons with DNAs encompassing a total of 2,500 bp each over three separate PCR-amplified fragments from KS lesions and body cavity-based lymphoma (BCBL) samples from 12 distinct patients, including four African and two classical or endemic non-AIDS KS samples. The results revealed differences at 37 of 2,500 nucleotide positions (i.e., 1.5% overall variation). However, the 12 HHV-8 genomes examined fell into three distinct but very narrow subgroupings (A, B, and C strains). All A strain isolates differed from B strain isolates at 16 positions, but of the eight U.S. samples tested, six were A strains, and these differed at no more than two positions among them. Similarly, three of the four African samples were B strains, which differed from each other at only one position. The two C strain genomes also displayed only one nucleotide variation, but they differed from all A strains at 26 positions and from all B strains at 20 positions. One C strain genome was present in all six independent lesions from an AIDS KS patient with disseminated disease, and the other represented a mosaic A/C recombinant genome from the HBL6 cell line derived from a BCBL tumor. Evaluation of previous data suggests that B and C strains may predominate in Africa and that A strains predominate in classical Mediterranean samples. Although both B and C strains are represented in U.S. AIDS patients, the majority (70 to 80%) of samples from the mid-East Coast region at least appear to be virtually identical, supporting the concept that they may all derive from the spread during the AIDS epidemic of a single recently transmitted infectious agent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032391      PMCID: PMC191364     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.

Authors:  M N Wrightham; J P Stewart; N J Janjua; S D Pepper; C Sample; C M Rooney; J R Arrand
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

2.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients.

Authors:  J A Ambroziak; D J Blackbourn; B G Herndier; R G Glogau; J H Gullett; A R McDonald; E T Lennette; J A Levy
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

3.  Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients.

Authors:  V Adams; W Kempf; M Schmid; B Müller; J Briner; G Burg
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

4.  Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma.

Authors:  G Giraldo; E Beth; E S Huang
Journal:  Int J Cancer       Date:  1980-07-15       Impact factor: 7.396

5.  Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients.

Authors:  P L Rady; A Yen; J L Rollefson; I Orengo; S Bruce; T K Hughes; S K Tyring
Journal:  Lancet       Date:  1995-05-27       Impact factor: 79.321

6.  Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies.

Authors:  I Boldogh; E Beth; E S Huang; S K Kyalwazi; G Giraldo
Journal:  Int J Cancer       Date:  1981-10-15       Impact factor: 7.396

7.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences.

Authors:  E Cesarman; P S Moore; P H Rao; G Inghirami; D M Knowles; Y Chang
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

8.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.

Authors:  D Whitby; M R Howard; M Tenant-Flowers; N S Brink; A Copas; C Boshoff; T Hatzioannou; F E Suggett; D M Aldam; A S Denton
Journal:  Lancet       Date:  1995-09-23       Impact factor: 79.321

9.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.

Authors:  C Boshoff; T F Schulz; M M Kennedy; A K Graham; C Fisher; A Thomas; J O McGee; R A Weiss; J J O'Leary
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  26 in total

1.  Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR.

Authors:  I E White; T B Campbell
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

Authors:  J C Zong; D M Ciufo; D J Alcendor; X Wan; J Nicholas; P J Browning; P L Rady; S K Tyring; J M Orenstein; C S Rabkin; I J Su; K F Powell; M Croxson; K E Foreman; B J Nickoloff; S Alkan; G S Hayward
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 3.  Evolutionary aspects of oncogenic herpesviruses.

Authors:  J Nicholas
Journal:  Mol Pathol       Date:  2000-10

4.  Human Herpesvirus 8 Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

5.  Characterization of human herpes virus 8 genotypes in Kaposi's sarcoma patients in Tehran, Iran.

Authors:  Kayhan Azadmanesh; Zeinab Sadat Norouzfar; Amir Sohrabi; Zahra Safaie-Naraghi; Afshin Moradi; Parichehre Yaghmaei; Mona Masoumeh Naraghi; Arash Arashkia; Ali Eslamifar
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

6.  Glycoprotein gene sequence variation in rhesus monkey rhadinovirus.

Authors:  Young C Shin; Leandro R Jones; Julieta Manrique; William Lauer; Angela Carville; Keith G Mansfield; Ronald C Desrosiers
Journal:  Virology       Date:  2010-02-20       Impact factor: 3.616

7.  Genomic variation of the fibropapilloma-associated marine turtle herpesvirus across seven geographic areas and three host species.

Authors:  Rebecca J Greenblatt; Sandra L Quackenbush; Rufina N Casey; Joel Rovnak; George H Balazs; Thierry M Work; James W Casey; Claudia A Sutton
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus K15 gene.

Authors:  Emily L Wong; Blossom Damania
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Geographically distinct HHV-8 DNA sequences in Saudi Arabian Iatrogenic Kaposi's sarcoma lesions.

Authors:  K E Foreman; S Alkan; A E Krueger; J R Panella; L J Swinnen; B J Nickoloff
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

10.  Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein.

Authors:  C P Pau; L L Lam; T J Spira; J B Black; J A Stewart; P E Pellett; R A Respess
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.